Log In
BCIQ
Print this Print this
 

EBX-001

  Manage Alerts
Collapse Summary General Information
Company EnBiotix Inc.
DescriptionCombination of tobramycin with a metabolite potentiator
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationPseudomonas
Indication DetailsTreat pseudomonas aeruginosa infections in cystic fibrosis (CF) patients; Treat pseudomonas aeruginosa infections in non-CF bronchiectasis patients; Treat pseudomonas aeruginosa infections in patients with COPD
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today